GLP-1 Medications Show Promise in Reducing Diabetes and Heart Risks More Effectively Than Metformin
Recent research indicates that GLP-1 receptor agonists, such as Ozempic and Mounjaro, may be more effective than the standard medication metformin in managing prediabetes and lowering the risk of transitioning to type 2 diabetes. This new finding could lead to alternative treatment strategies for individuals facing metabolic challenges. The study revealed that GLP-1 medications not…
